Back to Atlas
BSemi-durableStandard research/education caution
CMP-0203
Experimental
Humanin
Longevity / Cytoprotection
Cellular protection and metabolic resilience positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Mitochondrial peptide
- Primary mechanism
- Mitochondrial stress and cell-survival signaling
- Primary market use
- Longevity
Pharmacology
- Molecular weight (Da)
- ~2687
- Oral bioavailability
- N/A
- Half-life
- Short; not established
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Preclinical
- Clinical status
- Experimental
- Value-for-money score
- 5 / 10
Reported protocol signal
Treatment length: 30 days SQ: • 1 mg daily Note: The protocol is not clearly established yet. This one is frequently mentioned on Peppy’s, Discord servers.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Mitochondrial peptide class